federal_register: 2013-22644
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-22644 | Draft Guidance for Industry on Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products-Content and Format; Availability | Notice | The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products--Content and Format." The recommendations in the draft guidance are intended to help ensure that the labeling is clear, useful, informative, and to the extent possible, consistent in content and format. | 2013-09-18 | 2013 | 9 | https://www.federalregister.gov/documents/2013/09/18/2013-22644/draft-guidance-for-industry-on-patient-counseling-information-section-of-labeling-for-human | https://www.govinfo.gov/content/pkg/FR-2013-09-18/pdf/2013-22644.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products--Content and Format." The... |